뒤로
Poniard Pharmaceuticals Inc(PARD) 가격
PARD 주가 차트
PARD 수입
Poniard Pharmaceuticals Inc
$0
0%
$0
오늘 기준:Feb 10, 10:16:45 GMT-5
아직 데이터 없음Earnings FAQ
PARD의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Poniard Pharmaceuticals Inc PARD의 지난 분기 매출 실적은 어땠나요?
Poniard Pharmaceuticals Inc의 매출 추정치는 얼마인가요?
Poniard Pharmaceuticals Inc의 수익 품질 점수는 얼마인가요?
Poniard Pharmaceuticals Inc는 언제 수익을 보고하나요?
Poniard Pharmaceuticals Inc의 예상 수익은 얼마인가요?
Poniard Pharmaceuticals Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0001
시가
$0.0001
일일 범위
$0.0001 - $0.0001
52주 범위
$0.0001 - $0.0001
거래량
7
평균 거래량
161
EPS(TTM)
-11.78
배당수익률
--
시가총액
$150
PARD란 무엇인가요?
Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.